Rehmann Capital Advisory Group’s Syneos Health, Inc. Class A Common Stock SYNH Stock Holding History

Rehmann Capital Advisory Group’s Portfolio SYNH Stock Details SYNH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	$16.1K	Sell	303 -36	-11%	-$1.85K	﹤0.01%	924
2019 Q2	$17.3K	Sell	339 -56	-14%	-$2.61K	﹤0.01%	1185
2019 Q1	$20.4K	Buy	395 +2	+0.5%	+$97	﹤0.01%	1115
2018 Q4	$15.5K	Hold	393	–	–	﹤0.01%	925
2018 Q3	$20.3K	Sell	393 -14	-3%	-$685	﹤0.01%	1118
2018 Q2	$19.1K	Buy	407 +19	+5%	+$786	﹤0.01%	1121
2018 Q1	$14K	Buy	+388	New	+$15.2K	﹤0.01%	1204

Other funds holding SYNH

Advent International Boston, Massachusetts $4.24B AUM 4.24% 1-Year Est. Return

THLTP

Thomas H. Lee (THL) Partners Boston, Massachusetts $205M AUM 1.84% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return

ACH

ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Rehmann Capital Advisory Group's SYNH Position: Q3 2019 in Review

Rehmann Capital Advisory Group reduced its Syneos Health, Inc. Class A Common Stock (SYNH) stake by 11% in Q3 2019, selling an estimated $1.85K and leaving 303 shares worth $16.1K. The position accounts for ﹤0.01% of the portfolio, ranked #924.

Rehmann Capital Advisory Group first reported a position in SYNH in Q1 2018 and has held it in 7 quarters since. The position peaked at $20.4K in Q1 2019. 259 funds tracked by Wall St. Rank hold SYNH as of Q3 2019.

Rehmann Capital Advisory Group held 303 shares of Syneos Health, Inc. Class A Common Stock worth $16.1K as of Q3 2019.
Rehmann Capital Advisory Group sold 36 Syneos Health, Inc. Class A Common Stock shares in Q3 2019, an estimated $1.85K.
Syneos Health, Inc. Class A Common Stock made up ﹤0.01% of Rehmann Capital Advisory Group's portfolio in Q3 2019, its #924 holding.
Rehmann Capital Advisory Group first reported a position in Syneos Health, Inc. Class A Common Stock in Q1 2018 and has held it in 7 quarters since.
Rehmann Capital Advisory Group's Syneos Health, Inc. Class A Common Stock position peaked at $20.4K in Q1 2019.
259 funds tracked by Wall St. Rank held Syneos Health, Inc. Class A Common Stock as of Q3 2019.

Based on Rehmann Capital Advisory Group's 13F filing for Q3 2019, filed 2 Jan 2020.